Role of ribophorin II in the response to anticancer drugs in gastric cancer cell lines

Oncology Letters
Tein-Ming YuanShow-Mei Chuang

Abstract

The identification of prognostic markers and establishing their value as therapeutic targets improves therapeutic efficacy against human cancers. Ribophorin II (RPN2) has been demonstrated to be a prognostic marker of human cancer, including breast and pancreatic cancers. The present study aimed to evaluate RPN2 expression in gastric cancer and to examine the possible correlation between RPN2 expression and the response of cells to clinical anticancer drugs, which has received little research attention at present. The gastric cancer AGS, TMC-1, SNU-1, TMK-1, SCM-1, MKN-45 and KATO III cell lines were used as a model to elucidate the role of RPN2 in the response of cells to six common chemotherapeutic agents, comprising oxaliplatin, irinotecan, doxorubicin, docetaxel, cisplatin and 5-fluorouricil. The functional role of RPN2 was assessed by silencing RPN2 using small interfering RNA (siRNA), and the cytotoxicity was determined by an MTS assay and analysis of apoptosis. Molecular events were evaluated by western blotting. All the anticancer drugs were found to exert a concentration-dependent decrease on the cell survival rate of each of the cell lines tested, although the RPN2 levels in the various cell lines were not directly co...Continue Reading

References

May 1, 1984·Cancer Genetics and Cytogenetics·M P DavisH C Hoagland
Jun 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M M Le BeauC A Westbrook
Dec 1, 2005·Glycobiology·Daniel J Kelleher, Reid Gilmore
Mar 6, 2007·Critical Reviews in Oncology/hematology·David J Stewart
Aug 30, 2008·Nature Medicine·Kimi HonmaTakahiro Ochiya
Jun 12, 2009·Drug Metabolism Reviews·Lesley A StanleyC Roland Wolf
May 10, 2011·Molecular Cancer Therapeutics·Raquel De SouzaMicheline Piquette-Miller
Feb 22, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kevin G Chen, Branimir I Sikic
Mar 14, 2012·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Brian C ShafferMichael M Gottesman

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis
PCR
glycosylation

Related Concepts

Related Feeds

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis